Funding news for global health researchers: January 16, 2023

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Special Announcements

Pre-Application Webinar

Fogarty and other NIH participating Institutes, Centers, and Offices will be hosting a pre-application technical assistance webinar to aid potential applicants for PAR-23-042 and PAR-23-043: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments.

• When: January 18 at 9 a.m. ET
  
• Register online
  

Request for Information: Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries

The National Cancer Institute (NCI) is soliciting input about how to increase high-quality cancer therapeutic clinical trials in low- and middle-income countries (LMICs) as well as the key research priorities for such clinical trials. This RFI is part of the NCI Center for Global Health’s (CGH) effort to further the conduct of cancer therapeutic clinical trials in LMICs.

• Request for Information (RFI): Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries (NOT-CA-23-015)
  

Free open access publishing in Nature journals for researchers from LMICs

Springer Nature announced that primary research from authors from World Bank-classified low- and middle-income countries (LMICs) accepted for publication in either Nature or one of the Nature research journals can now be published open access at no cost.

• Nature announces support for authors from over 70 countries to publish open access

Upcoming Deadlines for Fogarty Funding Opportunities

• Japanese Research Fellowships (JSPS)
  Application deadline: February 17, 2023
  
• International Research Scientist Development Award (IRSDA)
  Application deadline: March 8, 2023
  
• Upcoming deadlines for all Fogarty funding opportunities
  

Funding Opportunities

NIH and FDA funding opportunities focusing on global health and foreign collaboration:

• Social Drivers of Mental Illnesses in Low- & Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) (RFA-MH-23-310)
  Application receipt date: February 17, 2023
• Cooperative Agreement to Support the Food and Agriculture Organization (FAO) (U01) Clinical Trials Not Allowed (RFA-FD-23-020)
  Application receipt date: March 7, 2023
• Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed. (RFA-FD-23-007)
  Application receipt date: March 7, 2023
• International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) (RFA-AI-22-067)
  Application receipt date: May 5, 2023

NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:

• Using Just-in-Time Adaptive Interventions to Optimize Established Adolescent Mental Health Treatments (R61/R33 Clinical Trial Required) (RFA-MH-23-170)
  Application receipt date(s): February 22, 2023
• Pediatric Heart Network Clinical Research Centers (UM1 Clinical Trial Optional) (RFA-HL-24-001)
  Application receipt date(s): May 12, 2023
• Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional) (PAR-23-060)
  Application receipt date(s): Multiple dates, see announcement.
• Innovations to Optimize HIV Prevention and Care Continuum Outcomes funding opportunities:
  • (R21 Clinical Trial Optional) (PAR-23-061)
    Application receipt date(s): Multiple dates, see announcement.
  • (R01 Clinical Trial Optional) (PAR-23-062)
    Application receipt date(s): Multiple dates, see announcement.
• In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) (PAR-23-074)
  Application receipt date(s): Multiple dates, see announcement.
• Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-23-082)
  Application receipt date(s): Multiple dates, see announcement.
• Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (PAR-23-087)
  Application receipt date(s): Multiple dates, see announcement.
• Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) (PAR-23-084)
  Application receipt date(s): Multiple dates, see announcement.
• Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional) (PAR-23-101)
  Application receipt date(s): Multiple dates, see announcement.
• Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional) (PAR-23-102)
  Application receipt date(s): Multiple dates, see announcement.
• Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) (PAR-23-105)
  Application receipt date(s): Multiple dates, see announcement.

NIH funding opportunities for which foreign components may apply:

• Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) (RFA-HL-24-004)
  Application receipt date(s): March 10, 2023
• Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed) (RFA-DE-23-014)
  Application receipt date(s): April 14, 2023
• Accelerating Data and Metadata Standards in the Environmental Health Sciences (R24 Clinical Trial Not Allowed) (RFA-ES-23-002)
  Application receipt date(s): May 10, 2023
• Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) (PAR-22-261)
  Application receipt date(s): Multiple dates, see announcement
• NIDA Program Project Grant Applications (P01 Clinical Trial Optional) (PAR-23-064)
  Application receipt date(s): Multiple dates, see announcement
• NIAID Physician-Scientist Pathway to Independence Award funding opportunities:
  • (K99/R00 Clinical Trial Required) (PAR-23-070)
    Application receipt date(s): Multiple dates, see announcement
  • (K99/R00 Independent Clinical Trial Not Allowed) (PAR-23-071)
    Application receipt date(s): Multiple dates, see announcement
• NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) (PAR-23-076)
  Application receipt date(s): Multiple dates, see announcement
• Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed) (RFA-AG-24-001)
  Application receipt date(s): Multiple dates, see announcement
• Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed) (RFA-OD-23-001)
  Application receipt date(s): Multiple dates, see announcement

Other Funding News

Other funding updates that may be of interest to global health researchers.

General NIH notices:

• Request for Information (RFI): Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries
• Notice of Information to Expire the PAR-21-311, Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
• Notice of Information to Expire PAR-21-319, Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trials Optional)

Notice of changes to NIH funding opportunities:

• Notice to Extend the Expiration Date of PAR-20-156 "Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimer’s Disease (R01 Clinical Trial Optional)" (NOT-AG-22-051)

Notices of intent to publish funding opportunities:

• Notice of Intent to Publish a Funding Opportunity Announcement for Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) (NOT-DA-23-014)

NIH Notices of Special Interest (NOSIs):

• Administrative Supplement to Support Global Cancer Stigma Research
  Expiration date: May 22, 2023
• Adaptive Biomaterials for Cancer Biology
  Expiration date: May 7, 2025
• Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases
  Expiration date: January 8, 2026
• Administrative Supplements to Support Programs for Inclusion and Diversity Among Individuals Engaged in Health-Related Research (PRIDE) Small Research Projects (SRPs)
  Expiration date: November 2, 2027

Non-NIH funding opportunities:

• Elhra is requesting proposals to develop a standard operational package of measures to prevent food insecurity that will result in a contract award.
  Deadline: January 23, 2023
  

• Summer Research Program for Undergraduate Life Science Students at the Swiss Federal Institute of Technology is now accepting applications. The program offers intensive hands-on research training at one of four institutes, including a Global Health Institute. Fellowships provided.
  Application deadline: January 31, 2023
• USAID is seeking applications to implement the HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) Project to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates.  
  Application deadline: March 28, 2023
• More non-NIH funding opportunities

Training Opportunities

• Raising a Resilient Scientist Series runs through March 2023: The NIH Office of Intramural Training & Education (OITE) is offering a five-unit series covering communication, resilience, inclusivity, conflict and feedback, and trainee wellbeing to help extramural PIs support biomedical trainees.

Abstract Submission Opportunities

• INTEREST 2023 encourages early-career investigators, researchers, and other healthcare professionals from around the world to submit abstracts and help shape the INTEREST 2023 program. The annual INTEREST Conference is the premier scientific conference for HIV in Africa:
  • Meeting dates: May 9–12, 2023
  • Deadline: February 3, 2023
    
    

Events

Events for global health researchers:

• January 18
  Virtual: GACD Pre-Application Technical Assistance Webinar
  Fogarty and other NIH participating Institutes, Centers, and Offices will be hosting a pre-application technical assistance webinar to aid potential applicants for PAR-23-042 and PAR-23-043: Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments.
• January 19
  Virtual: Ecological Grief & Anxiety: A Healthy Response to Climate Change
  Part of the NIMH Director's Innovation Speaker Series
• January 19
  Virtual: Mpox: Learnings from Effective Science and Human Rights-Based Responses
  Fogarty Senior Scientist Emeritus Joel Breman, panelist
  Hosted by USC Institute on Inequalities in Global Health and UCLA Center for Global and Immigrant Health
• January 23-24
  London, United Kingdom: International Conference on Global Health
  Sponsored by World Academy of Science, Engineering and Technology (WASET)
• January 24-25
  Virtual: Generalist Repository Ecosystem Initiative (GREI) Workshop
  Hosted by the NIH Office of Data Science Strategy